Cargando…

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum

Detalles Bibliográficos
Autores principales: Uriu, Keiya, Kimura, Izumi, Shirakawa, Kotaro, Takaori-Kondo, Akifumi, Nakada, Taka-aki, Kaneda, Atsushi, Nakagawa, So, Sato, Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609602/
https://www.ncbi.nlm.nih.gov/pubmed/34731554
http://dx.doi.org/10.1056/NEJMc2114706
_version_ 1784602951087554560
author Uriu, Keiya
Kimura, Izumi
Shirakawa, Kotaro
Takaori-Kondo, Akifumi
Nakada, Taka-aki
Kaneda, Atsushi
Nakagawa, So
Sato, Kei
author_facet Uriu, Keiya
Kimura, Izumi
Shirakawa, Kotaro
Takaori-Kondo, Akifumi
Nakada, Taka-aki
Kaneda, Atsushi
Nakagawa, So
Sato, Kei
author_sort Uriu, Keiya
collection PubMed
description
format Online
Article
Text
id pubmed-8609602
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Massachusetts Medical Society
record_format MEDLINE/PubMed
spelling pubmed-86096022021-11-23 Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum Uriu, Keiya Kimura, Izumi Shirakawa, Kotaro Takaori-Kondo, Akifumi Nakada, Taka-aki Kaneda, Atsushi Nakagawa, So Sato, Kei N Engl J Med Correspondence Massachusetts Medical Society 2021-11-03 /pmc/articles/PMC8609602/ /pubmed/34731554 http://dx.doi.org/10.1056/NEJMc2114706 Text en Copyright © 2021 Massachusetts Medical Society. All rights reserved. http://www.nejmgroup.org/legal/terms-of-use.htm This article is made available via the PMC Open Access Subset for unrestricted re-use, except commercial resale, and analyses in any form or by any means with acknowledgment of the original source. PMC is granted a license to make this article available via PMC and Europe PMC, subject to existing copyright protections.
spellingShingle Correspondence
Uriu, Keiya
Kimura, Izumi
Shirakawa, Kotaro
Takaori-Kondo, Akifumi
Nakada, Taka-aki
Kaneda, Atsushi
Nakagawa, So
Sato, Kei
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
title Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
title_full Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
title_fullStr Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
title_full_unstemmed Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
title_short Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
title_sort neutralization of the sars-cov-2 mu variant by convalescent and vaccine serum
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609602/
https://www.ncbi.nlm.nih.gov/pubmed/34731554
http://dx.doi.org/10.1056/NEJMc2114706
work_keys_str_mv AT uriukeiya neutralizationofthesarscov2muvariantbyconvalescentandvaccineserum
AT kimuraizumi neutralizationofthesarscov2muvariantbyconvalescentandvaccineserum
AT shirakawakotaro neutralizationofthesarscov2muvariantbyconvalescentandvaccineserum
AT takaorikondoakifumi neutralizationofthesarscov2muvariantbyconvalescentandvaccineserum
AT nakadatakaaki neutralizationofthesarscov2muvariantbyconvalescentandvaccineserum
AT kanedaatsushi neutralizationofthesarscov2muvariantbyconvalescentandvaccineserum
AT nakagawaso neutralizationofthesarscov2muvariantbyconvalescentandvaccineserum
AT satokei neutralizationofthesarscov2muvariantbyconvalescentandvaccineserum